- REPORT SUMMARY
- TABLE OF CONTENTS
-
Herpes labialis, also known as cold sores, is a type of infection by the herpes simplex virus that affects primarily the lip. Symptoms typically include a burning pain followed by small blisters or sores. The first attack may also be accompanied by fever, sore throat, and enlarged lymph nodes. The rash usually heals within 10 days, but the virus remains dormant in the facial nerve. The virus may periodically reactivate to create another outbreak of sores in the mouth or lip.
With over 35% value share, North America stood the top market for herpes labialis treatment in 2019. This region is expected to continue its dominance through the forecast period, followed by Western Europe, which recorded over 20% share of the total market value in 2019.
The report details the trend, potential and market size of Herpes Labialis Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Herpes Labialis Treatmentmarket, defines the market attractiveness level of Herpes Labialis Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Herpes Labialis Treatment industry, describes the types of Herpes Labialis Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Herpes Labialis Treatment market and the development prospects and opportunities of Herpes Labialis Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Herpes Labialis Treatment market in Chapter 13.
By Player:
Dr Reddy's
Sun
Abbott
Pfizer
Novartis
Mylan
GlaxoSmithKline
Teva
By Type:
Acyclovir
Valacyclovir
Famciclovir
Penciclovir
Docosanol
By End-User:
Topical
Oral
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Herpes Labialis Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Herpes Labialis Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Herpes Labialis Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Herpes Labialis Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Herpes Labialis Treatment Market Analysis and Outlook to 2022
-
7.1 Global Herpes Labialis Treatment Consumption (2017-2022)
-
7.2 United States Herpes Labialis Treatment Consumption (2017-2022)
-
7.3 Europe Herpes Labialis Treatment Consumption (2017-2022)
-
7.4 China Herpes Labialis Treatment Consumption (2017-2022)
-
7.5 Japan Herpes Labialis Treatment Consumption (2017-2022)
-
7.6 India Herpes Labialis Treatment Consumption (2017-2022)
-
7.7 South Korea Herpes Labialis Treatment Consumption (2017-2022)
8 Region and Country-wise Herpes Labialis Treatment Market Analysis and Outlook to 2028
-
8.1 Global Herpes Labialis Treatment Consumption Forecast (2022-2028)
-
8.2 United States Herpes Labialis Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Herpes Labialis Treatment Consumption Forecast (2022-2028)
-
8.4 China Herpes Labialis Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Herpes Labialis Treatment Consumption Forecast (2022-2028)
-
8.6 India Herpes Labialis Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Herpes Labialis Treatment Consumption Forecast (2022-2028)
9 Global Herpes Labialis Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Herpes Labialis Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Acyclovir Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Valacyclovir Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Famciclovir Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Penciclovir Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Docosanol Consumption and Growth Rate (2017-2022)
-
9.2 Global Herpes Labialis Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Topical Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Oral Consumption and Growth Rate (2017-2022)
10 Global Herpes Labialis Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Herpes Labialis Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Acyclovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Valacyclovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Famciclovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Penciclovir Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Docosanol Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Herpes Labialis Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Oral Consumption Forecast and Growth Rate (2022-2028)
11 Global Herpes Labialis Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Herpes Labialis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Herpes Labialis Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Herpes Labialis Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Herpes Labialis Treatment Market Competitive Analysis
-
14.1 Dr Reddy's
-
14.1.1 Dr Reddy's Company Details
-
14.1.2 Dr Reddy's Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Dr Reddy's Herpes Labialis Treatment Product and Service
-
14.2 Sun
-
14.2.1 Sun Company Details
-
14.2.2 Sun Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sun Herpes Labialis Treatment Product and Service
-
14.3 Abbott
-
14.3.1 Abbott Company Details
-
14.3.2 Abbott Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Abbott Herpes Labialis Treatment Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Herpes Labialis Treatment Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Herpes Labialis Treatment Product and Service
-
14.6 Mylan
-
14.6.1 Mylan Company Details
-
14.6.2 Mylan Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mylan Herpes Labialis Treatment Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Herpes Labialis Treatment Product and Service
-
14.8 Teva
-
14.8.1 Teva Company Details
-
14.8.2 Teva Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Teva Herpes Labialis Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Herpes Labialis Treatment
-
Figure Herpes Labialis Treatment Picture
-
Table Global Herpes Labialis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Herpes Labialis Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Herpes Labialis Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Herpes Labialis Treatment Consumption by Country (2017-2022)
-
Figure United States Herpes Labialis Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Herpes Labialis Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Herpes Labialis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Herpes Labialis Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Herpes Labialis Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Herpes Labialis Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Herpes Labialis Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Herpes Labialis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Herpes Labialis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Herpes Labialis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Herpes Labialis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Herpes Labialis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Herpes Labialis Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Acyclovir Consumption and Growth Rate (2017-2022)
-
Figure Global Valacyclovir Consumption and Growth Rate (2017-2022)
-
Figure Global Famciclovir Consumption and Growth Rate (2017-2022)
-
Figure Global Penciclovir Consumption and Growth Rate (2017-2022)
-
Figure Global Docosanol Consumption and Growth Rate (2017-2022)
-
Figure Global Topical Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Acyclovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Valacyclovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Famciclovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Penciclovir Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Docosanol Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Topical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Herpes Labialis Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Herpes Labialis Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Dr Reddy's (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Herpes Labialis Treatment Product and Service
-
Table Sun (Foundation Year, Company Profile and etc.)
-
Table Sun Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Herpes Labialis Treatment Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Herpes Labialis Treatment Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Herpes Labialis Treatment Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Herpes Labialis Treatment Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Herpes Labialis Treatment Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Herpes Labialis Treatment Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Herpes Labialis Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Herpes Labialis Treatment Product and Service
-